Novo Nordisk prints €6bn after CEO departs

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Corporate Bonds

Novo Nordisk prints €6bn after CEO departs

Mike Turner
May 20, 2025 04:26 PM
Wegovy Semaglutide Pens close up

◆ Novo Nordisk brings €6bn trade days after CEO leaves ◆ Tranches priced with similar premiums ◆ No sign of investor fatigue for jumbo corporate trades

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Corporate BondsHigh grade and crossover bondsEuropeEuroDenmark
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article